Biofrontera Inc. (BFRI)
NASDAQ: BFRI · IEX Real-Time Price · USD
1.540
+0.400 (35.09%)
At close: Mar 28, 2024, 4:00 PM
1.500
-0.040 (-2.60%)
After-hours: Mar 28, 2024, 7:07 PM EDT

Biofrontera Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-20.13-0.64-37.71-10.99-10.98
Depreciation & Amortization
1.061.170.540.560.67
Share-Based Compensation
1.051.850.1300
Other Operating Activities
-6.87-18.5810.33-1.94-27.36
Operating Cash Flow
-24.9-16.2-26.72-12.37-37.68
Capital Expenditures
-0.01-0.04-0.010-0.54
Acquisitions
0.62-5.120025.93
Investing Cash Flow
0.62-5.16-0.01025.4
Share Issuance / Repurchase
4.5114.0243.1900
Debt Issued / Paid
3.90013.1916.4
Financing Cash Flow
8.4114.0243.1913.1916.4
Net Cash Flow
-15.87-7.3316.470.834.12
Free Cash Flow
-24.9-16.24-26.73-12.37-38.22
Free Cash Flow Margin
-73.08%-56.63%-110.90%-65.62%-145.96%
Free Cash Flow Per Share
-16.10-15.36-60.68-10795.55-764300.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).